Changes in OCT-Angiography of type 2 CNV in neovascular AMD during anti-VEGF treatment.

被引：0
|
作者：
Faatz, Henrik [1 ]
Farecki, Marie-Louise [1 ]
Heimes, Britta [1 ]
Kai, Rothaus [1 ]
Lommatzsch, Albrecht [1 ]
Pauleikhoff, Daniel [1 ]
机构：
[1] St Franziskus Hosp Munster, Munster, Nrw, Germany
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2017年 / 58卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
403
引用
收藏
页数：3
相关论文
共 50 条
  • [41] FREQUENCY OF INTRAVITREAL INJECTIONS POST CATARACT SURGERY IN PATIENTS RECEIVING ANTI-VEGF TREATMENT FOR NEOVASCULAR AMD
    Enright, Nicholas J.
    McGuinness, Myra B.
    Parikh, Sumit
    Fotis, Kathy
    Guymer, Robyn H.
    Sandhu, Sukhpal S.
    Finger, Robert P.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 44 : 132 - 132
  • [42] Retrospective analysis of OCT parameters after intravitreal anti-VEGF inhibitors in neovascular AMD patients in a real-world setting
    Jan Niklas Lüke
    Hamdi Alquoqa
    Ahmad Alsamman
    Bayan Aljabary
    F. Schaub
    L. M. Heindl
    International Ophthalmology, 2023, 43 : 13 - 25
  • [43] Bacillary Detachment in Neovascular AMD: Incidence, SD-OCT Compartmental Features, and Response to Anti-VEGF Therapy in the HAWK Study
    Yordi, Sari
    Wise, Katherine
    Lunasco, Leina
    Cetin, Hasan
    Talcott, Katherine
    Srivastava, Sunil K.
    Hu, Joanne
    Zahid, Robert
    Ehlers, Justis P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [44] Choroidal Changes After Anti-VEGF Therapy in AMD Eyes With Different Types of Macular Neovascularization Using Swept-Source OCT Angiography
    Shen, Mengxi
    Zhou, Hao
    Lu, Jie
    Li, Jianqing
    Jiang, Xiaoshuang
    Trivizki, Omer
    Laiginhas, Rita
    Liu, Jeremy
    Zhang, Qinqin
    de Sisternes, Luis
    Feuer, William J.
    O'Brien, Robert
    Gregori, Giovanni
    Wang, Ruikang K.
    Rosenfeld, Philip J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (13)
  • [45] Retrospective analysis of OCT parameters after intravitreal anti-VEGF inhibitors in neovascular AMD patients in a real-world setting
    Lueke, Jan Niklas
    Alquoqa, Hamdi
    Alsamman, Ahmad
    Aljabary, Bayan
    Schaub, F.
    Heindl, L. M.
    INTERNATIONAL OPHTHALMOLOGY, 2023, 43 (01) : 13 - 25
  • [46] Association between VEGF-A and VEGFR-2 polymorphisms and response to treatment of neovascular AMD with anti-VEGF agents: a meta-analysis
    Wu, Mingxing
    Xiong, Haibo
    Xu, Yan
    Xiong, Xiaojing
    Zou, Hongmi
    Zheng, Minming
    Wang, Xiuqing
    Zhou, Xiyuan
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2017, 101 (07) : 976 - 984
  • [47] Retinal and choroidal changes after anti-VEGF therapy in neovascular-AMD patients: A systematic review and meta-analysis of SD-OCT studies
    Salehi, Mohammad Amin
    Frounchi, Negin
    Zakavi, Seyed Sina
    Mohammadi, Soheil
    Harandi, Hamid
    Shojaei, Shayan
    Gouravani, Mahdi
    Arevalo, J. Fernando
    SURVEY OF OPHTHALMOLOGY, 2024, 69 (04) : 547 - 557
  • [48] Optical coherence tomography angiography changes in early type 3 neovascularization after anti-VEGF treatment
    Miere, Alexandra
    Querques, Giuseppe
    Semoun, Oudy
    Amoroso, Francesca
    Zambrowski, Olivia
    Chapron, Thibaut
    Capuano, Vittorio
    Souied, Eric
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [49] Development and External Validation of a Machine Learning Model for Predicting Response to anti-VEGF Treatment in Patients with neovascular AMD
    Jones, Ian Lloyd
    Maunz, Andreas
    Albrecht, Thomas
    Lu, Huanxiang
    Li, Yvonna
    Benmansour, Fethallah
    Sahni, Jayashree Nair
    Gliem, Martin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (09)
  • [50] ANO2 Genetic Variants and Anti-VEGF Treatment Response in Neovascular AMD: A Pharmacogenetic Substudy of VIEW 1 and VIEW 2
    Guymer, Robyn H.
    Silva, Rufino
    Ghadessi, Mercedeh
    Leal, Sergio
    Gashaw, Isabella
    Damask, Amy
    Paulding, Charles
    Rittenhouse, Kay D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (08) : 17
12345